Skribe Advances Wearable Heart Monitoring for Cancer Patients
San Francisco, California, U.S., November 11, 2026 Skribe Medical has announced significant progress in developing its Aurora wearable cardiac...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
San Francisco, California, U.S., November 11, 2026 Skribe Medical has announced significant progress in developing its Aurora wearable cardiac...
Montreal, Quebec, Canada, November 11, 2026 AI4Eyes Medical Technologies Inc. has announced the successful completion of U.S. Food and...
Parsippany, New Jersey, USA, November 6, 2026 Onkos Surgical, Inc., a medical technology company specializing in advanced solutions for...
Wixom, Michigan, USA, November 3, 2026 Rockwell Medical, Inc. has announced a major global acquisition agreement with Vantive Limited,...
BURLINGTON, Massachusetts, October 29, 2026 Instylla, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved...
Minneapolis, Minnesota, U.S., September 24, 2026 Marani Health has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
Sunnyvale, California, September 23, 2026 GRAIL, Inc. announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics...
London, United Kingdom, September 22, 2026 Smith+Nephew has announced U.S. FDA 510(k) clearance for its LANDMARKâ„¢ Total Knee System...
Miami Lakes, Florida, U.S., September 21, 2026 Cordis has announced that the U.S. Food and Drug Administration (FDA) has...
India, September 18, 2026 Concept Medical is highlighting new subgroup findings from the SirPAD randomized clinical trial that will...
